van Deventer SJ - Search Results

1

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.

Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L. Braat H, et al. Among authors: van deventer sj. Clin Gastroenterol Hepatol. 2006 Jun;4(6):754-9. doi: 10.1016/j.cgh.2006.03.028. Epub 2006 May 22. Clin Gastroenterol Hepatol. 2006. PMID: 16716759 Clinical Trial.

2

Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease.

Hommes DW, van Deventer SJ. Hommes DW, et al. Among authors: van deventer sj. Curr Opin Clin Nutr Metab Care. 2000 May;3(3):191-5. doi: 10.1097/00075197-200005000-00005. Curr Opin Clin Nutr Metab Care. 2000. PMID: 10871234 Review.

3

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.

Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P. Huibregtse IL, et al. Among authors: van deventer sj. Gastroenterology. 2007 Aug;133(2):517-28. doi: 10.1053/j.gastro.2007.04.073. Epub 2007 May 3. Gastroenterology. 2007. PMID: 17681173

4

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. van Dullemen HM, et al. Among authors: van deventer sj. Gastroenterology. 1995 Jul;109(1):129-35. doi: 10.1016/0016-5085(95)90277-5. Gastroenterology. 1995. PMID: 7797011 Clinical Trial.

5

Leptin is a growth factor for colonic epithelial cells.

Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Hardwick JC, et al. Among authors: van deventer sj, van den brink gr. Gastroenterology. 2001 Jul;121(1):79-90. doi: 10.1053/gast.2001.25490. Gastroenterology. 2001. PMID: 11438496

6

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

ten Hove T, van Montfrans C, Peppelenbosch MP, van Deventer SJ. ten Hove T, et al. Among authors: van deventer sj, van montfrans c. Gut. 2002 Feb;50(2):206-11. doi: 10.1136/gut.50.2.206. Gut. 2002. PMID: 11788561 Free PMC article.

7

Infliximab therapy in Crohn's disease: safety issues.

Hommes DW, van Deventer SJ. Hommes DW, et al. Among authors: van deventer sj. Neth J Med. 2003 Apr;61(4):100-4. Neth J Med. 2003. PMID: 12852717 Free article. Review.

8

T cell apoptosis and inflammatory bowel disease.

Peppelenbosch MP, van Deventer SJ. Peppelenbosch MP, et al. Among authors: van deventer sj. Gut. 2004 Nov;53(11):1556-8. doi: 10.1136/gut.2004.040824. Gut. 2004. PMID: 15479669 Free PMC article. Review. No abstract available.

9

Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease.

Florie J, Horsthuis K, Hommes DW, Nio CY, Reitsma JB, van Deventer SJ, Stoker J. Florie J, et al. Among authors: van deventer sj. Clin Gastroenterol Hepatol. 2005 Dec;3(12):1221-8. doi: 10.1016/s1542-3565(05)00853-0. Clin Gastroenterol Hepatol. 2005. PMID: 16361048

10

Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function.

Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S. Braat H, et al. Am J Clin Nutr. 2004 Dec;80(6):1618-25. doi: 10.1093/ajcn/80.6.1618. Am J Clin Nutr. 2004. PMID: 15585777 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

436 results

Search Page